Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
Jacqui Nimmo(UK Dementia Research Institute), Roxana O. Carare(University of Southampton), Matthew MacGregor Sharp(University of Southampton), Roy O. Weller(Banner Sun Health Research Institute), James A. R. Nicoll(University of Southampton), Ajay Verma, David A. Johnston(University of Southampton), Jean‐Cosme Dodart
Cited by 24
Related Papers
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
|Nature Neuroscience|2002|858
Cerebral Amyloid Angiopathy
|American Journal Of Pathology|1998|682
Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease
|Molecular Medicine|2003|277
A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide Vaccine
|Movement Disorders|2022|51
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
|Alzheimer s Research & Therapy|2020|48